Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 31;41(14):2317-2319.
doi: 10.1016/j.vaccine.2023.02.065. Epub 2023 Mar 2.

Placing a value on increased flexible vaccine manufacturing capacity for future pandemics

Anthony T Newall  1 , Philippe Beutels  2 , Zoltán Kis  3 , Adrian Towse  4 , Mark Jit  5
Affiliations

Placing a value on increased flexible vaccine manufacturing capacity for future pandemics

Anthony T Newall et al. Vaccine. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Philippe Beutels reports a relationship with Pfizer that includes: consulting or advisory. Philippe Beutels reports a relationship with Merck that includes: funding grants. Philippe Beutels reports a relationship with European Commission Innovative Medicine Initiative that includes: funding grants. Adrian Towse reports a relationship with Pharmaceutical companies that includes: consulting or advisory. Adrian Towse reports a relationship with Office of Health Economics that includes: employment. Please see Conflict of Interest statement in submitted article for further detail.

References

    1. Plotkin S., et al. The complexity and cost of vaccine manufacturing - An overview. Vaccine. 2017;35(33):4064–4071. - PMC - PubMed
    1. Daniel S., et al. Quality by Design for enabling RNA platform production processes. Trends Biotechnol. 2022 - PubMed
    1. Kis Z., et al. Pandemic-response adenoviral vector and RNA vaccine manufacturing. npj Vaccines. 2022;7(1):29. - PMC - PubMed
    1. Blakney A.K., Bekker L.G. DNA vaccines join the fight against COVID-19. Lancet. 2022;399(10332):1281–1282. - PMC - PubMed
    1. Monrad J.T., Sandbrink J.B., Cherian N.G. Promoting versatile vaccine development for emerging pandemics. npj Vaccines. 2021;6(1):26. - PMC - PubMed

Publication types

MeSH terms

Substances